Ideas and updates for teams leading change, strengthening learning, and building commercial excellence.
A privately held pharmaceutical company was preparing for the commercial launch of their first prescription drug. The Executive Management team brought their commercial leaders...
Read the article
While a global pharmaceutical company was under a Corporate Integrity Agreement (CIA), an associated brand was issued Risk Evaluation Mitigation Strategies (REMS) requirements.
Read the article
A rapidly growing biotech company was interested in improving organizational efficiency and sales performance. As part of the effort, they conducted a critical review...
Read the article
In the past five years, the Department of Justice (DOJ) has levied almost $22 billion in fines against pharmaceutical companies for compliance violations. In...
Read the article
Given the heightened scrutiny that pharmaceutical companies face in today’s marketplace, all communication is discoverable and could lead to increased regulatory penalties and negative...
Read the article
The opioid abuse epidemic in the United States has grown dramatically in recent years. The number of opioid prescriptions in the U.S. increased from 144...
Read the article
The primary responsibility of pharmaceutical compliance professionals is to ensure their organizations adhere to government requirements and all company activities align with regulatory policies....
Read the article
Companies need to identify and mitigate risks across the full range of sales’ job functions, not just when they are out in the field...
Read the article